The role of T helper cells in neuroprotection and regeneration

被引:127
作者
Hendrix, Sven [1 ]
Nitsch, Robert [1 ]
机构
[1] Univ Med Berlin, Inst Cell Biol & Neurobiol, Ctr Anat, Charite, D-10098 Berlin, Germany
关键词
Th2; protective autoimmunity; immunosuppression; CNS wound healing; traumatic brain injury; spinal cord injury;
D O I
10.1016/j.jneuroim.2006.11.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The inflammatory wound healing response of the central nervous system (CNS) following mechanical injury is characterized by at least one or two phases of T cell infiltration. Surprisingly, whether T cells play a beneficial or detrimental role in these processes is still controversial. It has been suggested that autoimmune T cells may provide "protective autoimmunity", however, after CNS injury, injections of autoimmune T cells and vaccine strategies led to both improvement in some models and exacerbation of the damage in others. Here, we review increasing evidence that a specific T cell subpopulation, namely T helper cells type 2 (Th2 cells) are particularly beneficial in the context of CNS lesions. CNS injuries such as mechanical lesions or stroke induce a systemic immunosuppression, which is characterized by a systemic shift towards a Th2 cytokine pattern. Simplified, this systemic Th2 shift results in reduced cell-mediated immune responses, and, to a lesser extent, humoral immune responses. Furthermore, treatment with potent Th2 inducers such as glatiramer acetate or statins, as well as vaccination strategies using Th2-inducing adjuvants for immunization such as aluminum hydroxide, result in increased neuroprotection and regeneration - without development of autoimmune CNS inflammation. Thus, it is tempting to speculate that a systemic Th2 shift is part of a necessary CNS wound healing response after injury, by furthering regeneration and preventing autoimmune disease of the CNS. Within this context, investigating the potential of a systemic Th2 shift to improve outcome after CNS injury, including the control of possible side-effects such as increased susceptibility to infection and allergic responses, is extremely promising. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:100 / 112
页数:13
相关论文
共 106 条
[1]   Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin [J].
Aktas, O ;
Waiczies, S ;
Smorodchenko, A ;
Dörr, J ;
Seeger, B ;
Prozorovski, T ;
Sallach, S ;
Endres, M ;
Brocke, S ;
Nitsch, R ;
Zipp, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :725-733
[2]   Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis [J].
Angelov, DN ;
Waibel, S ;
Guntinas-Lichius, O ;
Lenzen, M ;
Neiss, WF ;
Tomov, TL ;
Yoles, E ;
Kipnis, J ;
Schori, H ;
Reuter, A ;
Ludolph, A ;
Schwartz, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) :4790-4795
[3]   Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells [J].
Arora, Meenakshi ;
Chen, Li ;
Paglia, Melissa ;
Gallagher, Iain ;
Allen, Judith E. ;
Vyas, Yatin M. ;
Ray, Anuradha ;
Ray, Prabir .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) :7777-7782
[4]  
Babcock AA, 2003, J NEUROSCI, V23, P7922
[5]   T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure [J].
Bakalash, S ;
Ben Shlomo, G ;
Aloni, E ;
Shaked, I ;
Wheeler, L ;
Ofri, R ;
Schwartz, M .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11) :904-916
[6]   Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease [J].
Benner, EJ ;
Mosley, RL ;
Destache, CJ ;
Lewis, TB ;
Jackson-Lewis, V ;
Gorantla, S ;
Nemachek, C ;
Green, SR ;
Przedborski, S ;
Gendelman, HE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (25) :9435-9440
[7]   TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin [J].
Biedermann, T ;
Röcken, M ;
Carballido, JM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (01) :5-14
[8]   Call for Elan to publish Alzheimer's trial details [J].
Bishop, GM ;
Robinson, SR ;
Smith, MA ;
Perry, G ;
Atwood, CS .
NATURE, 2002, 416 (6882) :677-677
[9]   Cytokine production pathway in the elderly [J].
Caruso, C ;
Candore, G ;
Cigna, D ;
DiLorenzo, G ;
Sireci, G ;
Dieli, F ;
Salerno, A .
IMMUNOLOGIC RESEARCH, 1996, 15 (01) :84-90
[10]   Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nursing home residents [J].
Castle, S ;
Uyemura, K ;
Wong, W ;
Modlin, R ;
Effros, R .
MECHANISMS OF AGEING AND DEVELOPMENT, 1997, 94 (1-3) :7-16